Amyloid precursor protein and mitochondria.


Journal

Current opinion in neurobiology
ISSN: 1873-6882
Titre abrégé: Curr Opin Neurobiol
Pays: England
ID NLM: 9111376

Informations de publication

Date de publication:
02 2023
Historique:
received: 22 09 2022
revised: 28 10 2022
accepted: 31 10 2022
pmc-release: 01 02 2024
pubmed: 4 12 2022
medline: 18 1 2023
entrez: 3 12 2022
Statut: ppublish

Résumé

Amyloid Precursor Protein (APP) processing to amyloid beta (Aβ) is a major hallmark of Alzheimer's disease (AD). The amyloid cascade hypothesis postulates that Aβ accumulation and aggregation causes AD, however many therapeutics targeting Aβ have failed recently. Decades of research describe metabolic deficits in AD. Mitochondrial dysfunction is observed in AD subjects within the brain and systemically. APP and γ-secretase are localized to mitochondria. APP can be processed within mitochondria and its localization to mitochondria affects function. Here we discuss the evidence showing APP and γ-secretase localize to mitochondria. We also discuss the implications for the function of APP and its cleavage products in regulating mitochondrial function.

Identifiants

pubmed: 36462447
pii: S0959-4388(22)00145-3
doi: 10.1016/j.conb.2022.102651
pmc: PMC9845182
mid: NIHMS1847985
pii:
doi:

Substances chimiques

Amyloid beta-Peptides 0
Amyloid beta-Protein Precursor 0
Amyloid Precursor Protein Secretases EC 3.4.-
APP protein, human 0

Types de publication

Journal Article Review Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

102651

Subventions

Organisme : NIA NIH HHS
ID : P30 AG035982
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG072973
Pays : United States
Organisme : NIA NIH HHS
ID : R00 AG056600
Pays : United States

Informations de copyright

Copyright © 2022 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare no conflicts.

Références

FASEB J. 2011 Jan;25(1):78-88
pubmed: 20833873
J Cell Biol. 2003 Apr 14;161(1):41-54
pubmed: 12695498
J Biol Chem. 2004 Nov 26;279(48):50310-20
pubmed: 15371443
Cell. 1995 May 19;81(4):525-31
pubmed: 7758106
J Biol Chem. 2012 Aug 31;287(36):30317-27
pubmed: 22753410
J Alzheimers Dis. 2022;85(1):381-394
pubmed: 34806611
J Biol Chem. 2016 Aug 12;291(33):17209-27
pubmed: 27325702
Transl Neurodegener. 2021 Sep 1;10(1):33
pubmed: 34465385
J Alzheimers Dis. 2017;55(4):1549-1570
pubmed: 27911326
Adv Exp Med Biol. 2012;942:269-86
pubmed: 22399427
Int J Mol Sci. 2020 Aug 14;21(16):
pubmed: 32824102
Neurobiol Dis. 2022 Sep;171:105781
pubmed: 35667615
Mech Ageing Dev. 2009 Sep;130(9):592-601
pubmed: 19622370
Cells. 2019 May 22;8(5):
pubmed: 31121890
J Neurosci. 2006 Aug 30;26(35):9057-68
pubmed: 16943564
Proc Natl Acad Sci U S A. 2007 Aug 28;104(35):14163-8
pubmed: 17715058
Curr Alzheimer Res. 2016;13(1):2-6
pubmed: 26487155
Glia. 2019 May;67(5):985-998
pubmed: 30667091
Biochim Biophys Acta. 2014 Sep;1842(9):1340-9
pubmed: 24747741
Sci Rep. 2016 Feb 29;6:22244
pubmed: 26924205
J Biol Chem. 2004 Dec 3;279(49):51654-60
pubmed: 15456764
Proc Natl Acad Sci U S A. 2009 Nov 24;106(47):20057-62
pubmed: 19897719
Curr Opin Struct Biol. 2022 Jun;74:102373
pubmed: 35461161
Proc Natl Acad Sci U S A. 2008 Sep 2;105(35):13145-50
pubmed: 18757748
EMBO J. 2017 Nov 15;36(22):3356-3371
pubmed: 29018038
PLoS One. 2016 Dec 22;11(12):e0168157
pubmed: 28005987
Brain Res Bull. 2017 Jul;133:71-79
pubmed: 27545490
EMBO J. 2012 Nov 5;31(21):4106-23
pubmed: 22892566
Cell Rep. 2021 May 18;35(7):109134
pubmed: 34010653
Neurochem Int. 2010 Nov;57(6):668-75
pubmed: 20705111
Alzheimers Dement. 2023 Jan;19(1):333-342
pubmed: 35522844
Biochem Biophys Res Commun. 2017 Apr 29;486(2):321-328
pubmed: 28302486
Acta Neuropathol. 2021 Jan;141(1):39-65
pubmed: 33079262
Neurobiol Aging. 2013 Oct;34(10):2399-2407
pubmed: 23702344
Front Cell Dev Biol. 2020 Jul 16;8:595
pubmed: 32766245
Neurobiol Dis. 2012 Jan;45(1):417-24
pubmed: 21933711
Sci Rep. 2017 Aug 29;7(1):9835
pubmed: 28852095

Auteurs

Taylor A Strope (TA)

University of Kansas Alzheimer's Disease Center, Kansas City, KS, USA; Department of Biochemistry and Molecular Biology, University of Kansas Medical Center, Kansas City, KS, USA. Electronic address: https://twitter.com/OneDayDrTay.

Heather M Wilkins (HM)

University of Kansas Alzheimer's Disease Center, Kansas City, KS, USA; Department of Biochemistry and Molecular Biology, University of Kansas Medical Center, Kansas City, KS, USA; Department of Neurology University of Kansas Medical Center, Kansas City, KS, USA. Electronic address: hwilkins@kumc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH